175 related articles for article (PubMed ID: 7522081)
1. Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors.
Strohmeyer T
World J Urol; 1994; 12(2):74-8. PubMed ID: 7522081
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of protooncogenes in human germ cell tumors of the testis.
Shuin T; Misaki H; Kubota Y; Yao M; Hosaka M
Cancer; 1994 Mar; 73(6):1721-7. PubMed ID: 7908857
[TBL] [Abstract][Full Text] [Related]
3. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue.
Strohmeyer T; Reese D; Press M; Ackermann R; Hartmann M; Slamon D
J Urol; 1995 Feb; 153(2):511-5. PubMed ID: 7529338
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
5. Annulate lamellae in a large cell lung carcinoma cell line with high expression of tyrosine kinase receptor and proto-oncogenes.
Wang NS; Liu C; Emond J; Tsao MS
Ultrastruct Pathol; 1992; 16(4):439-49. PubMed ID: 1354400
[TBL] [Abstract][Full Text] [Related]
6. Predominant expression of fibroblast growth factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors.
Suzuki K; Tokue A; Kamiakito T; Kuriki K; Saito K; Tanaka A
Virchows Arch; 2001 Nov; 439(5):616-21. PubMed ID: 11764380
[TBL] [Abstract][Full Text] [Related]
7. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
[TBL] [Abstract][Full Text] [Related]
8. Experimental Sertoli cell tumors in the mouse and their progression into a mixed germ cell-sex cord proliferation.
Paquis-Flucklinger V; Rassoulzadegan M; Michiels JF
Am J Pathol; 1994 Mar; 144(3):454-9. PubMed ID: 7510454
[TBL] [Abstract][Full Text] [Related]
9. [Malignant testicular tumors: cytogenetic and molecular biology principles].
Strohmeyer T
Urologe A; 1993 May; 32(3):201-6. PubMed ID: 8511833
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss and somatic differentiation in human male germ cell tumors.
Murty VV; Bosl GJ; Houldsworth J; Meyers M; Mukherjee AB; Reuter V; Chaganti RS
Oncogene; 1994 Aug; 9(8):2245-51. PubMed ID: 7518576
[TBL] [Abstract][Full Text] [Related]
11. DNA amplifications and elevated expression of proto-oncogene in addition to altered DNA ploidy in metastatic brain tumors.
Arai T; Ichimura K; Hirakawa K; Yuasa Y
Clin Exp Metastasis; 1994 Jul; 12(4):267-75. PubMed ID: 7913669
[TBL] [Abstract][Full Text] [Related]
12. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors.
Strohmeyer T; Peter S; Hartmann M; Munemitsu S; Ackermann R; Ullrich A; Slamon DJ
Cancer Res; 1991 Apr; 51(7):1811-6. PubMed ID: 1706218
[TBL] [Abstract][Full Text] [Related]
13. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular germ cell tumors.
Schmidt B; Ackermann R; Hartmann M; Strohmeyer T
J Urol; 1997 Nov; 158(5):2000-5. PubMed ID: 9334657
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene.
Tsuda H; Tsugane S; Fukutomi T; Nanasawa T; Yamamoto H; Hirohashi S
Jpn J Clin Oncol; 1992 Aug; 22(4):244-9. PubMed ID: 1359174
[TBL] [Abstract][Full Text] [Related]
16. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the promoter region of the human c-kit proto-oncogene.
Yamamoto K; Tojo A; Aoki N; Shibuya M
Jpn J Cancer Res; 1993 Nov; 84(11):1136-44. PubMed ID: 7506248
[TBL] [Abstract][Full Text] [Related]
18. k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development.
de Anta JM; Monzó M; Peris B; Ruano D
Histol Histopathol; 1997 Jan; 12(1):33-41. PubMed ID: 9046041
[TBL] [Abstract][Full Text] [Related]
19. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas.
Lese CM; Rossie KM; Appel BN; Reddy JK; Johnson JT; Myers EN; Gollin SM
Genes Chromosomes Cancer; 1995 Apr; 12(4):288-95. PubMed ID: 7539284
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-Myc, TGF-alpha and EGF-receptor in sporadic medullary thyroid carcinoma.
Wang W; Johansson HE; Bergholm UI; Westermark KM; Grimelius LE
Acta Oncol; 1997; 36(4):407-11. PubMed ID: 9247102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
